Skip to main content

Outlook Therapeutics, Inc. (NASDAQ: OTLK) Investor Securities Class Action Lawsuit 11/03/2023

  • If you purchased a significant amount of shares of Outlook Therapeutics, Inc. (NASDAQ: OTLK) between December 29, 2022 and August 29, 2023, and / or if you purchased any NASDAQ: OTLK shares prior to December 2022 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: January 2, 2024. NASDAQ: OTLK investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

April 24, 2024 - A consolidated amended complaint was filed. November 03, 2023 - An investor in shares of Outlook Therapeutics, Inc. (NASDAQ: OTLK) filed a lawsuit in the U.S. District Court for the District of New Jersey over alleged violations of Federal Securities Laws by Outlook Therapeutics, Inc. in connection with certain allegedly false and misleading statements made between De...



You must register (for free) or login to view the entire case.